OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7578$33.5056

Revivegen Co Ltd

Environmental Services & EquipmentVerified

Revivegen operates with a debt-to-equity ratio of 3.29, indicating a capital structure heavily reliant on debt financing. The company's liquidity is assessed as medium, with negative net cash after subtracting total debt, suggesting potential short-term liquidity constraints. Operating cash flow of TWD 172.66 million is insufficient to cover capital expenditures of TWD -1.308 billion, highlighting a significant cash outflow from investment activities. Profitability metrics show a market price of TWD 33.5 and an enterprise value to revenue ratio of 14.82, which is higher than the typical valuation for environmental services firms, suggesting a premium valuation relative to revenue. The company's return on invested capital (ROIC) and operating margins are not disclosed, but the high debt load may pressure future returns if operating cash flows do not expand. The company's revenue is concentrated in the domestic market, with no disclosed international operations, and it operates in a single business segment focused on waste treatment and recycling. This geographic and segment concentration increases exposure to local economic and regulatory shifts. For the current fiscal year, revenue is expected to remain stable, with no significant growth or contraction projected. The company's capital expenditures are expected to remain high, driven by the need to maintain and expand waste treatment infrastructure. The company's risk profile includes medium liquidity risk due to negative net cash and a high debt-to-equity ratio. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. The absence of dilution risk is supported by the company's current share structure, where basic and diluted shares are equal. Recent filings and transcripts do not disclose material events or strategic shifts, but the company's capital expenditure outflow suggests ongoing investment in operations. No recent earnings calls or regulatory filings indicate significant changes in business strategy or risk exposure.

30-day price · 7578-1.35 (-4.0%)
Low$31.65High$40.00Close$32.60As of15 May, 00:00 UTC
Profile
CompanyRevivegen Co Ltd
Ticker7578.TWO
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryEnvironmental Services & Equipment
AI analysis

Business. Revivegen Co Ltd provides waste incineration and physical treatment services, primarily for organic solvent waste, and sells recycled solvents and steam generated from waste treatment processes in the domestic market.

Classification. Revivegen is classified under the Environmental Services & Equipment industry within the Industrial & Commercial Services business sector, with a confidence level of 0.92.

Revivegen operates with a debt-to-equity ratio of 3.29, indicating a capital structure heavily reliant on debt financing. The company's liquidity is assessed as medium, with negative net cash after subtracting total debt, suggesting potential short-term liquidity constraints. Operating cash flow of TWD 172.66 million is insufficient to cover capital expenditures of TWD -1.308 billion, highlighting a significant cash outflow from investment activities. Profitability metrics show a market price of TWD 33.5 and an enterprise value to revenue ratio of 14.82, which is higher than the typical valuation for environmental services firms, suggesting a premium valuation relative to revenue. The company's return on invested capital (ROIC) and operating margins are not disclosed, but the high debt load may pressure future returns if operating cash flows do not expand. The company's revenue is concentrated in the domestic market, with no disclosed international operations, and it operates in a single business segment focused on waste treatment and recycling. This geographic and segment concentration increases exposure to local economic and regulatory shifts. For the current fiscal year, revenue is expected to remain stable, with no significant growth or contraction projected. The company's capital expenditures are expected to remain high, driven by the need to maintain and expand waste treatment infrastructure. The company's risk profile includes medium liquidity risk due to negative net cash and a high debt-to-equity ratio. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. The absence of dilution risk is supported by the company's current share structure, where basic and diluted shares are equal. Recent filings and transcripts do not disclose material events or strategic shifts, but the company's capital expenditure outflow suggests ongoing investment in operations. No recent earnings calls or regulatory filings indicate significant changes in business strategy or risk exposure.
Key takeaways
  • Revivegen's capital structure is highly leveraged, with a debt-to-equity ratio of 3.29, indicating significant reliance on debt financing.
  • The company's liquidity is assessed as medium, with negative net cash after subtracting total debt, signaling potential short-term cash flow constraints.
  • Revenue is concentrated in the domestic market, with no international operations disclosed, increasing exposure to local economic and regulatory risks.
  • Capital expenditures are expected to remain high, driven by the need to maintain and expand waste treatment infrastructure.
  • Dilution risk is low, with no near-term pressure from share issuance or convertible instruments.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$469.2M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$172.7M
CapEx-$1.31B
Free cash flow
Total assets
Total liabilities$6.44B
Total equity$1.50B
Cash & equivalents
Long-term debt$4.94B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$33.50
Market cap$2.01B
Enterprise value$6.95B
P/E
Reported non-GAAP P/E
EV/Revenue14.8
EV/Op income
EV/OCF40.3
P/B
P/Tangible book
Tangible book
Net cash-$4.94B
Current ratio
Debt/Equity3.3
ROA
ROE
Cash conversion
CapEx/Revenue-2.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
Metric7578Activity
Op margin11.2% medp25 7.1% · p75 18.5%
Net margin13.8% medp25 13.8% · p75 13.8%
Gross margin94.7% medp25 62.9% · p75 126.4%
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-278.9%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity329.0%136.7% medp25 101.5% · p75 217.7%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 04:37 UTC#15b7bda8
Market quoteclose TWD 33.50 · shares 0.06B diluted
no public URL
2026-05-10 04:37 UTC#bd3f36cb
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 04:40 UTCJob: 88122e5d